Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.
Brief Summary: This 2 arm study assessed the efficacy of Mycophenolate Mofetil (MMF; CellCept) compared to cyclophosphamide in inducing a response in patients with lupus nephritis, and the long term efficacy of MMF compared to azathioprine in maintaining remission and renal function. Patients were randomized to receive either MMF (1.5 g twice daily \[bid\]) or cyclophosphamide (0.5-1.0 g/m\^2 in monthly pulses) in the induction phase. Those patients meeting criteria for response were re-randomized for entry into the maintenance phase, to receive either MMF (1 g bid) or azathioprine (2 mg/kg/day).


Options:
A: Arm Label: Low dose Cyclophosphamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Azathioprine, Drug: Methylprednisolone | Arm Label: High Dose Cyclophosphamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Azathioprine, Drug: Methylprednisolone | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): High Dose Cyclophosphamide, Low dose Cyclophosphamide | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): High Dose Cyclophosphamide, Low dose Cyclophosphamide | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): High Dose Cyclophosphamide, Low dose Cyclophosphamide
B: Arm Label: FK506+MMF; Type: ACTIVE_COMPARATOR; Interventions: Drug: Multitherapy | Intervention Type: DRUG; Name: Multitherapy; Assigned to Arm(s): FK506+MMF
C: Arm Label: Atacicept Plus Mycophenolate mofetil Plus Corticosteroids; Type: EXPERIMENTAL; Interventions: Drug: Atacicept, Drug: Mycophenolate mofetil, Drug: Corticosteroids | Arm Label: Placebo Plus Mycophenolate mofetil Plus Corticosteroids; Type: PLACEBO_COMPARATOR; Interventions: Drug: Mycophenolate mofetil, Drug: Placebo, Drug: Corticosteroids | Intervention Type: DRUG; Name: Atacicept; Assigned to Arm(s): Atacicept Plus Mycophenolate mofetil Plus Corticosteroids | Intervention Type: DRUG; Name: Mycophenolate mofetil; Assigned to Arm(s): Atacicept Plus Mycophenolate mofetil Plus Corticosteroids, Placebo Plus Mycophenolate mofetil Plus Corticosteroids | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Plus Mycophenolate mofetil Plus Corticosteroids | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): Atacicept Plus Mycophenolate mofetil Plus Corticosteroids, Placebo Plus Mycophenolate mofetil Plus Corticosteroids
D: Arm Label: Induction Phase: Mycophenolate mofetil; Type: EXPERIMENTAL; Interventions: Drug: Mycophenolate mofetil (MMF), Drug: Corticosteroid | Arm Label: Induction Phase: Cyclophosphamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Corticosteroid | Arm Label: Maintenance Phase: Mycophenolate mofetil; Type: EXPERIMENTAL; Interventions: Drug: Mycophenolate mofetil (MMF), Drug: Placebo to Azathioprine, Drug: Corticosteroid | Arm Label: Maintenance Phase: Azathioprine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azathioprine, Drug: Placebo to Mycophenolate mofetil, Drug: Corticosteroid | Intervention Type: DRUG; Name: Mycophenolate mofetil (MMF); Assigned to Arm(s): Induction Phase: Mycophenolate mofetil, Maintenance Phase: Mycophenolate mofetil | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Induction Phase: Cyclophosphamide | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): Maintenance Phase: Azathioprine | Intervention Type: DRUG; Name: Placebo to Azathioprine; Assigned to Arm(s): Maintenance Phase: Mycophenolate mofetil | Intervention Type: DRUG; Name: Placebo to Mycophenolate mofetil; Assigned to Arm(s): Maintenance Phase: Azathioprine | Intervention Type: DRUG; Name: Corticosteroid; Assigned to Arm(s): Induction Phase: Cyclophosphamide, Induction Phase: Mycophenolate mofetil, Maintenance Phase: Azathioprine, Maintenance Phase: Mycophenolate mofetil

Answer: D